P&K Skin Research Center Co (XKRX:347740) 3-Year EBITDA Growth Rate : -10.90% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is P&K Skin Research Center Co 3-Year EBITDA Growth Rate?

P&K Skin Research Center Co's EBITDA per Share for the three months ended in Dec. 2023 was ₩92.45.

During the past 12 months, P&K Skin Research Center Co's average EBITDA Per Share Growth Rate was -27.00% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -10.90% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -22.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of P&K Skin Research Center Co was 3.20% per year. The lowest was -74.50% per year. And the median was -34.55% per year.

Competitive Comparison of P&K Skin Research Center Co's 3-Year EBITDA Growth Rate

For the Diagnostics & Research subindustry, P&K Skin Research Center Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

P&K Skin Research Center Co's 3-Year EBITDA Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, P&K Skin Research Center Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where P&K Skin Research Center Co's 3-Year EBITDA Growth Rate falls into.

P&K Skin Research Center Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

P&K Skin Research Center Co (XKRX:347740) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

P&K Skin Research Center Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of P&K Skin Research Center Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

P&K Skin Research Center Co (XKRX:347740) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » P&K Skin Research Center Co Ltd (XKRX:347740) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

National Assembly Road 62 -25 Yeongdeungpo-gu, Education Facility Disaster Relief Society Building, 4th Floor, Seoul, KOR, 07236

Website

http://www.pnkskin.com

P&K Skin Research Center Co Ltd is a skin research center. It provides clinical tests for new cosmetics, raw materials, and cosmeceuticals. The company provides skin irritation tests, Stimulation tests, skin wrinkle evaluation, skin texture evaluation, skin whitening evaluation, sweat proof evaluation, skin density measurement, scalp flakiness evaluation, and hair root evaluation. Also, the company provides health food tests, sensory tests, and In Vitro tests.

P&K Skin Research Center Co (XKRX:347740) Headlines

No Headlines